These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 8475098)

  • 21. Targeted mutagenesis of simian virus 40 DNA mediated by a triple helix-forming oligonucleotide.
    Havre PA; Glazer PM
    J Virol; 1993 Dec; 67(12):7324-31. PubMed ID: 8230456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered repair of targeted psoralen photoadducts in the context of an oligonucleotide-mediated triple helix.
    Wang G; Glazer PM
    J Biol Chem; 1995 Sep; 270(38):22595-601. PubMed ID: 7673252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific inhibition of c-fos proto-oncogene expression by triple-helix-forming oligonucleotides.
    Lavrovsky Y; Mastyugin V; Stoltz RA; Abraham NG
    J Cell Biochem; 1996 May; 61(2):301-9. PubMed ID: 9173093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blocking transcription of the human rhodopsin gene by triplex-mediated DNA photocrosslinking.
    Intody Z; Perkins BD; Wilson JH; Wensel TG
    Nucleic Acids Res; 2000 Nov; 28(21):4283-90. PubMed ID: 11058128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ionizing radiation activates nuclear factor kappa B but fails to produce an increase in human immunodeficiency virus gene expression in stably transfected human cells.
    Valerie K; Laster WS; Kirkham JC; Kuemmerle NB
    Biochemistry; 1995 Dec; 34(48):15768-76. PubMed ID: 7495808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus.
    Doerre S; Sista P; Sun SC; Ballard DW; Greene WC
    Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1023-7. PubMed ID: 8430069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2).
    Burysek L; Yeow WS; Pitha PM
    J Hum Virol; 1999; 2(1):19-32. PubMed ID: 10200596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of c-myc transcription by triple helix formation.
    Postel EH
    Ann N Y Acad Sci; 1992 Oct; 660():57-63. PubMed ID: 1340156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design of bifunctional oligonucleotide intercalator conjugates as inhibitors of gene expression.
    Helene C; Thuong NT
    Nucleic Acids Symp Ser; 1991; (24):133-7. PubMed ID: 1668684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of abasic linker substitution on triplex formation, Sp1 binding, and specificity in an oligonucleotide targeted to the human Ha-ras promoter.
    Mayfield C; Miller D
    Nucleic Acids Res; 1994 May; 22(10):1909-16. PubMed ID: 8208618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triple helix-forming oligonucleotide corresponding to the polypyrimidine sequence in the rat alpha 1(I) collagen promoter specifically inhibits factor binding and transcription.
    Kovacs A; Kandala JC; Weber KT; Guntaka RV
    J Biol Chem; 1996 Jan; 271(3):1805-12. PubMed ID: 8576186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequence-specific labeling of superhelical DNA by triple helix formation and psoralen crosslinking.
    Pfannschmidt C; Schaper A; Heim G; Jovin TM; Langowski J
    Nucleic Acids Res; 1996 May; 24(9):1702-9. PubMed ID: 8649989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Triple-helix formation by oligonucleotides containing the three bases thymine, cytosine, and guanine.
    Giovannangéli C; Rougée M; Garestier T; Thuong NT; Hélène C
    Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8631-5. PubMed ID: 1528873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability of DNA triplexes on shuttle vector plasmids in the replication pool in mammalian cells.
    Lin FL; Majumdar A; Klotz LC; Reszka AP; Neidle S; Seidman MM
    J Biol Chem; 2000 Dec; 275(50):39117-24. PubMed ID: 10993885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of DNA binding proteins by oligonucleotide-directed triple helix formation.
    Maher LJ; Wold B; Dervan PB
    Science; 1989 Aug; 245(4919):725-30. PubMed ID: 2549631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted mutagenesis in mammalian cells mediated by intracellular triple helix formation.
    Wang G; Levy DD; Seidman MM; Glazer PM
    Mol Cell Biol; 1995 Mar; 15(3):1759-68. PubMed ID: 7862165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Site-specific targeting of psoralen photoadducts with a triple helix-forming oligonucleotide: characterization of psoralen monoadduct and crosslink formation.
    Gasparro FP; Havre PA; Olack GA; Gunther EJ; Glazer PM
    Nucleic Acids Res; 1994 Jul; 22(14):2845-52. PubMed ID: 8052539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding.
    Ganchi PA; Sun SC; Greene WC; Ballard DW
    Mol Biol Cell; 1992 Dec; 3(12):1339-52. PubMed ID: 1493333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel NF-kappa B element within exon 1 of the murine c-myc gene.
    Kessler DJ; Spicer DB; La Rosa FA; Sonenshein GE
    Oncogene; 1992 Dec; 7(12):2447-53. PubMed ID: 1461649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of replication initiation by triple helix-forming oligonucleotides.
    Guieysse AL; Praseuth D; Francois JC; Helene C
    Biochem Biophys Res Commun; 1995 Dec; 217(1):186-94. PubMed ID: 8526909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.